Form D · Biotechnology
Plasmonix, Inc.
Gaithersburg, MD · CIK 0001521534
Offering snapshot reported Jul 7, 2015 · SEC filing
- Reported sold
- $544K Offering amount: $565K
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 13, 2014 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$314,942 → $543,857
- Reported investors10 → 11
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 7, 2015 | Amendment | $543,857 | $228,915vs Jun 13, 2014 | 11 | SEC filing |
| Jun 13, 2014 | Initial | $314,942 | No comparison | 10 | SEC filing |
| Nov 13, 2013 | Initial | $231,069 | No comparison | 7 | SEC filing |
| Jul 3, 2013 | Initial | $300,000 | No comparison | 1 | SEC filing |
| Jun 7, 2012 | Initial | $298,264 | No comparison | 15 | SEC filing |
| Jun 21, 2011 | Initial | $1,217,417 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-219175
The amount sold refelcts the conversion of certain Company obligations in exchange for an equity issuance, in addition to cash proceeds.
Source: Form D, filed Jul 7, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jesse Baumgold, Ph D | Director, Executive |
| Christopher D. Geddes | Executive |
| William M. Gust, Ii | Director, Executive |
| Sean Higgins, Ph D | Executive |
| John W. Holaday | Director, Executive |
| David Manyak | Director |
| Steven Meltzer | Director |
| Edward M. Rudnic, Ph D | Director |
| James E. Russo | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9119 Gaither Road
Gaithersburg, MD, 20877
Gaithersburg, MD, 20877